Sinian Pan1, Shili Guo2, Liting Liu2, Xiaoyuan Yang2, Hanmei Liang2. 1. The Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, China. pansinian@163.com. 2. The Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, 510630, China.
Abstract
PURPOSE: This study aimed to present the clinical features and gene mutation characteristics of a child with 46,XY disorders of sex development (DSD) caused by a novel heterozygous mutation in the NR5A1 gene to determine the potential association between this heterozygous mutation and the pathogenesis of 46,XY DSD. METHODS: We present the case of a Chinese child with ambiguous genitalia at birth but a normal adrenal gland. Targeted next-generation sequencing, comprising 163 candidate genes involved in sexual differentiation and development, was performed, followed by the functional evaluation of the novel NR5A1 mutation. RESULT: The patient had a novel heterozygous mutation in the NR5A1 gene, c.630delG (p.Y211Tfs*85). Results revealed that overexpression of p.Y211Tfs*85 impaired steroidogenic factor-1 (SF-1) protein synthesis. Immunofluorescence analysis revealed that both SF-1 wild-type and p.Y211Tfs*85 mutation proteins were localized in the cell nucleus. Furthermore, dual-luciferase reporter assay results revealed that the p.Y211Tfs*85 mutation could effectively downregulate the transcriptional activation of anti-Müllerian hormone and steroidogenic acute regulatory protein genes (P < 0.01). Additionally, the p.Y211Tfs*85 mutation changed three-dimensional conformation of SF-1, and three conformations could be constructed with the mutated amino acid sequences. Therefore, the novel frameshift mutation could result in decreased protein expression of SF-1. CONCLUSION: We described a novel mutation in NR5A1 and showed that it might affect protein structure, thereby seriously compromising the role of SF-1 in regulating gonadal development. The novel p.Y211Tfs*85 mutation in the NR5A1 gene enriches the boy of information available regarding the mutation spectrum of this gene in the Chinese population.
PURPOSE: This study aimed to present the clinical features and gene mutation characteristics of a child with 46,XY disorders of sex development (DSD) caused by a novel heterozygous mutation in the NR5A1 gene to determine the potential association between this heterozygous mutation and the pathogenesis of 46,XY DSD. METHODS: We present the case of a Chinese child with ambiguous genitalia at birth but a normal adrenal gland. Targeted next-generation sequencing, comprising 163 candidate genes involved in sexual differentiation and development, was performed, followed by the functional evaluation of the novel NR5A1 mutation. RESULT: The patient had a novel heterozygous mutation in the NR5A1 gene, c.630delG (p.Y211Tfs*85). Results revealed that overexpression of p.Y211Tfs*85 impaired steroidogenic factor-1 (SF-1) protein synthesis. Immunofluorescence analysis revealed that both SF-1 wild-type and p.Y211Tfs*85 mutation proteins were localized in the cell nucleus. Furthermore, dual-luciferase reporter assay results revealed that the p.Y211Tfs*85 mutation could effectively downregulate the transcriptional activation of anti-Müllerian hormone and steroidogenic acute regulatory protein genes (P < 0.01). Additionally, the p.Y211Tfs*85 mutation changed three-dimensional conformation of SF-1, and three conformations could be constructed with the mutated amino acid sequences. Therefore, the novel frameshift mutation could result in decreased protein expression of SF-1. CONCLUSION: We described a novel mutation in NR5A1 and showed that it might affect protein structure, thereby seriously compromising the role of SF-1 in regulating gonadal development. The novel p.Y211Tfs*85 mutation in the NR5A1 gene enriches the boy of information available regarding the mutation spectrum of this gene in the Chinese population.
Entities:
Keywords:
AMH; Disorders of sex development; NR5A1; SF-1; STAR
Authors: Jonathan M Swartz; Ryan Ciarlo; Michael H Guo; Aser Abrha; Benjamin Weaver; David A Diamond; Yee-Ming Chan; Joel N Hirschhorn Journal: Horm Res Paediatr Date: 2016-11-18 Impact factor: 2.852
Authors: Jenifer P Suntharalingham; Federica Buonocore; Andrew J Duncan; John C Achermann Journal: Best Pract Res Clin Endocrinol Metab Date: 2015-07-14 Impact factor: 4.690
Authors: Anu Bashamboo; Patricia A Donohoue; Eric Vilain; Sandra Rojo; Pierre Calvel; Sumudu N Seneviratne; Federica Buonocore; Hayk Barseghyan; Nathan Bingham; Jill A Rosenfeld; Surya Narayan Mulukutla; Mahim Jain; Lindsay Burrage; Shweta Dhar; Ashok Balasubramanyam; Brendan Lee; Marie-Charlotte Dumargne; Caroline Eozenou; Jenifer P Suntharalingham; Ksh de Silva; Lin Lin; Joelle Bignon-Topalovic; Francis Poulat; Carlos F Lagos; Ken McElreavey; John C Achermann Journal: Hum Mol Genet Date: 2016-12-01 Impact factor: 6.150
Authors: Birgit Köhler; Lin Lin; Bruno Ferraz-de-Souza; Peter Wieacker; Peter Heidemann; Vanessa Schröder; Heike Biebermann; Dirk Schnabel; Annette Grüters; John C Achermann Journal: Hum Mutat Date: 2008-01 Impact factor: 4.878